Roderik M. Kortlever

Author

University of Cambridge ORCID

Also Known As

R M Kortlever, R. Kortlever, Roderik Kortlever, Roderik M. Kortlever

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge The Netherlands Cancer Institute University of California, San Francisco UCSF Helen Diller Family Comprehensive Cancer Center Cancer Research UK

About

Roderik M. Kortlever is an author at University of Cambridge specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.4K
2	Cell Biology	4	4	1K
3	Natural Sciences	2	2	98
4	Engineering	1	1	304
5	Biomolecular Engineering	1	1	51

Roderik M. Kortlever

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence Roderik M. Kortlever, Paul J. Higgins, René Bernards Nature Cell Biology Lifespan ExtensionReplicative SenescencePlasminogen Activator Inhibitor-1Cell RegulationCritical Downstream Target	2006	601
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression Roderik M. Kortlever, Nicole M. Sodir, Catherine H. Wilson, Cell	2017	542
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Christopher Abbosh, Alexander M. Frankell, Thomas Harrison, Nature EngineeringOncologic ImagingCancer DetectionMedicinePathology	2023	304
Selective activation of p53-mediated tumour suppression in high-grade tumours Melissa R. Junttila, Anthony N. Karnezis, Daniel Garcia, Nature Tumor BiologyP53-mediated Tumour SuppressionMedicineTumor SuppressorCancer Biology	2010	256
MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype Nicole M. Sodir, Roderik M. Kortlever, Valentin J.A. Barthet, Cancer Discovery	2020	182
TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 and Inhibits Senescence Thijn R. Brummelkamp, Roderik M. Kortlever, Merel Lingbeek, Journal of Biological Chemistry	2002	150
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer Björn von Eyß, Laura A. Jaenicke, Roderik M. Kortlever, Cancer Cell Breast OncologySignal TransductionMitochondrial FunctionMitochondrial DynamicMedicine	2015	141
Senescence, Wound Healing, and Cancer: the PAI-1 Connection Roderik M. Kortlever, René Bernards Cell Cycle	2006	83
Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma Laura Soucek, Joseph J. Buggy, Roderik M. Kortlever, Neoplasia	2011	58
Transforming Growth Factor-β Requires Its Target Plasminogen Activator Inhibitor-1 for Cytostatic Activity Roderik M. Kortlever, Jeroen H. Nijwening, René Bernards Journal of Biological Chemistry Cytostatic ActivityTgfbeta Target GeneCell ProliferationCell GrowthTumor Biology	2008	51

Page 1